Eytan Ruppin/ccr.cancer.gov
Jan 23, 2025, 14:07
Eytan Ruppin: How does ancestry influence cancer treatment in clinical trials?
Eytan Ruppin, Chief of the Cancer Data Science Laboratory, shared a post on X about recent article by him and colleagues published in Cancer Discovery:
“How does ancestry influence cancer treatment in clinical trials? In collab with Leng Han and Dr. Gordon Mills, we uncovered ancestry differences in trials, actionable genes, and several types of therapies.
Authors: Mei Luo, Jingwen Yang, Eytan Ruppin, Leng Han, Gordon Mills et al.
More posts featuring Eytan Ruppin.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 16:56
Feb 25, 2025, 15:10
Feb 25, 2025, 14:12
Feb 25, 2025, 14:04
Feb 25, 2025, 13:56
Feb 25, 2025, 13:46
Feb 25, 2025, 13:38